secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2023-08-18T23:59:59+00:00
Accession:  0001104659-23-093537
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical receives Nasdaq deficiency notice for stockholders' equity below $2.5M threshold
--------------------------------------------------------------------------------

- Nasdaq notified Journey Medical on Aug 15, 2023 of non-compliance with Listing Rule 5550(b)(1) requiring minimum $2.5M stockholders' equity; company reported equity of $5,000 as of June 30, 2023.
- Company has 45 calendar days to submit a plan to regain compliance; if accepted, Nasdaq may grant up to 180-day extension.
- Company also fails alternative standards: market value of listed securities at least $35M or net income of $500K in recent years.
- Trading continues on Nasdaq under symbol DERM; no immediate delisting effect but risk of suspension if compliance not regained.
- Company intends to take reasonable measures but gives no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465923093537/0001104659-23-093537-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465923093537/tm2324045d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-093537

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer